The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Iheezo
chloroprocaine hydrochloride ophthalmic gel · CHLOROPROCAINE HYDROCHLORIDE 24 mg/800mg · Gel · Ophthalmic · Harrow Eye, LLC
NDC 82667-0300-00 · 1 POUCH in 1 CARTON / 1 VIAL in 1 POUCH / 800 mg in 1 VIAL · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA216227
- TE code
- —
- Approval date
- Sep 27, 2022
- Patents / exclusivity
- 2 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11969403 | May 14, 2039 |
| patent | 10792271 | Sep 15, 2038 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of chloroprocaine hydrochloride ophthalmic gel (Gel)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Harrow Eye, LLC | CHLOROPROCAINE HYDROCHLORIDE 24 mg/800mg | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Iheezo — NDC 82667-0300-00," retrieved September 3, 2026, https://drugdashboards.com/drug/82667030000.
Free to cite with attribution — see how the data is put together.